{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T14:57:02Z","timestamp":1777301822984,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013327","name":"H Lundbeck A\/S","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jad.2024.07.018","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T05:58:27Z","timestamp":1721023107000},"page":"634-642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The Functioning Assessment Short Test (FAST): Clinically meaningful response threshold in patients with major depressive disorder receiving antidepressant treatment"],"prefix":"10.1016","volume":"363","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3605-7223","authenticated-orcid":false,"given":"Michael Cronquist","family":"Christensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon Nitschky","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0137-0666","authenticated-orcid":false,"given":"Iria","family":"Grande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2024.07.018_bb0005","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jad.2023.01.074","article-title":"Vortioxetine in patients with major depressive disorder and high levels of anxiety symptoms: an updated analysis of efficacy and tolerability","volume":"328","author":"Adair","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.07.018_bb0010","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jad.2016.07.015","article-title":"A meta-analysis of the efficacy of vortioxetine in patients with major depressive disorder (MDD) and high levels of anxiety symptoms","volume":"206","author":"Baldwin","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.07.018_bb0015","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jad.2017.12.056","article-title":"The effects of vortioxetine on cognitive performance in working patients with major depressive disorder: a short-term, randomized, double-blind, exploratory study","volume":"229","author":"Baune","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.07.018_bb0020","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.3390\/jcm8071046","article-title":"Lifetime psychotic symptoms, subthreshold depression and cognitive impairment as barriers to functional recovery in patients with bipolar disorder","volume":"8","author":"Bonn\u00edn","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jad.2024.07.018_bb0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jad.2018.07.045","article-title":"Thresholds for severity, remission and recovery using the functioning assessment short test (FAST) in bipolar disorder","volume":"240","author":"Bonn\u00edn","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.07.018_bb0030","first-page":"28","article-title":"The clinical global impressions scale: applying a research tool in clinical practice","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry (Edgmont)"},{"key":"10.1016\/j.jad.2024.07.018_bb0035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jad.2017.06.036","article-title":"Cognitive impairment as measured by the THINC-integrated tool (THINC-it): association with psychosocial function in major depressive disorder","volume":"222","author":"Cha","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.07.018_bb0040","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1017\/S1092852919000786","article-title":"Long-term functioning outcomes are predicted by cognitive symptoms in working patients with major depressive disorder treated with vortioxetine: results from the AtWoRC study","volume":"24","author":"Chokka","year":"2019","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2024.07.018_bb0045","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jad.2022.11.033","article-title":"The Motivation and Energy Inventory (MEI): analysis of the clinically relevant response threshold in patients with major depressive disorder and emotional blunting using data from the COMPLETE study","volume":"323","author":"Christensen","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.07.018_bb0050","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jad.2021.07.099","article-title":"Validation of the Oxford Depression Questionnaire: sensitivity to change, minimal clinically important difference, and response threshold for the assessment of emotional blunting","volume":"294","author":"Christensen","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.07.018_bb0055","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1177\/02698811221090627","article-title":"Effectiveness of vortioxetine in patients with major depressive disorder comorbid with generalized anxiety disorder: results of the RECONNECT study","volume":"36","author":"Christensen","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.07.018_bb0060","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jad.2018.11.034","article-title":"Validation of the University of California San Diego Performance-based skills assessment (UPSA) in major depressive disorder: replication and extension of initial findings","volume":"245","author":"Christensen","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.07.018_bb0065","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cct.2006.10.010","article-title":"Cognitive testing in early-phase clinical trials: development of a rapid computerized test battery and application in a simulated phase I study","volume":"28","author":"Collie","year":"2007","journal-title":"Contemp. Clin. Trials"},{"key":"10.1016\/j.jad.2024.07.018_bb0260","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jad.2015.07.013","article-title":"Predictors of impaired work functioning in employees with major depression in remission","volume":"185","author":"de Vries","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.07.018_bb0070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/occmed\/kqab142","article-title":"The impact of depression, anxiety and comorbidity on occupational outcomes","volume":"72","author":"Deady","year":"2022","journal-title":"Occup. Med. (Lond.)"},{"key":"10.1016\/j.jad.2024.07.018_bb0075","first-page":"321","article-title":"Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure","volume":"29","author":"Endicott","year":"1993","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jad.2024.07.018_bb0080","first-page":"176","article-title":"What is the overlap between subjective and objective cognitive impairments in MDD?","volume":"30","author":"Fava","year":"2018","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2024.07.018_bb0085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/YCO.0000000000000376","article-title":"Patients with anxious depression: overview of prevalence, pathophysiology and impact on course and treatment outcome","volume":"31","author":"Gaspersz","year":"2018","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.jad.2024.07.018_bb0090","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2024.07.018_bb0095","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","article-title":"Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"9","author":"GBD 2019 Mental Disorders Collaborators","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2024.07.018_bb0100","series-title":"US Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration","article-title":"ECDEU assessment manual for psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1016\/j.jad.2024.07.018_bb0105","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br. J. Med. Psychol."},{"key":"10.1016\/j.jad.2024.07.018_bb0110","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jad.2017.02.014","article-title":"Determination of a clinically important difference and definition of a responder threshold for the UCSD performance-based skills assessment (UPSA) in patients with major depressive disorder","volume":"213","author":"Harvey","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.07.018_bb0115","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jad.2013.05.048","article-title":"Predicting relapse in major depressive disorder using patient-reported outcomes of depressive symptom severity, functioning, and quality of life in the individual burden of illness index for depression (IBI-D)","volume":"151","author":"IsHak","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.07.018_bb0120","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/2040622316639769","article-title":"Patient-reported functioning in major depressive disorder","volume":"7","author":"IsHak","year":"2016","journal-title":"Ther. Adv. Chronic Dis."},{"key":"10.1016\/j.jad.2024.07.018_bb0125","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0197-2456(89)90005-6","article-title":"Measurement of health status. Ascertaining the minimal clinically important difference","volume":"10","author":"Jaeschke","year":"1989","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.jad.2024.07.018_bb0130","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1017\/S2045796015000189","article-title":"Anxious and non-anxious major depressive disorder in the World Health Organization world mental health surveys","volume":"24","author":"Kessler","year":"2015","journal-title":"Epidemiol. Psychiatr. Sci."},{"key":"10.1016\/j.jad.2024.07.018_bb0135","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.2147\/NDT.S175188","article-title":"Psychometric validation of the perceived deficits questionnaire \u2013 depression (PDQ-D) instrument in a survey of US and UK respondents","volume":"14","author":"Lam","year":"2018","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2024.07.018_bb0140","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1177\/0706743716659416","article-title":"Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 1. Disease burden and principles of care","volume":"61","author":"Lam","year":"2016","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.jad.2024.07.018_bb0145","series-title":"Neuropsychological Assessments","author":"Lezak","year":"1983"},{"key":"10.1016\/j.jad.2024.07.018_bb0150","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","volume":"392","author":"Malhi","year":"2018","journal-title":"Depression. Lancet."},{"key":"10.1016\/j.jad.2024.07.018_bb0155","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/schbul\/sbm014","article-title":"Development of a brief scale of everyday functioning in persons with serious mental illness","volume":"33","author":"Mausbach","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jad.2024.07.018_bb0160","doi-asserted-by":"crossref","first-page":"23m14780","DOI":"10.4088\/JCP.23m14780","article-title":"Head-to-head comparison of vortioxetine versus desvenlafaxine in patients with major depressive disorder with partial response to SSRI therapy: results of the VIVRE study","volume":"84","author":"McIntyre","year":"2023","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2024.07.018_bb0165","doi-asserted-by":"crossref","first-page":"pyw055","DOI":"10.1093\/ijnp\/pyw055","article-title":"The effects of vortioxetine on cognitive function in patients with major depressive disorder: a meta-analysis of three randomized controlled trials","volume":"19","author":"McIntyre","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.jad.2024.07.018_bb0170","first-page":"20","article-title":"Treating to target in major depressive disorder: response to remission to functional recovery","volume":"20","author":"McIntyre","year":"2015","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2024.07.018_bb0175","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.07.018_bb0180","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.2147\/PPA.S138750","article-title":"Recovery in patients with major depressive disorder (MDD): results of a 6-month, multinational, observational study","volume":"11","author":"Novick","year":"2017","journal-title":"Patient Prefer. Adherence"},{"key":"10.1016\/j.jad.2024.07.018_bb0185","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jad.2022.07.009","article-title":"Residual cognitive and psychosocial functional impairment in outpatients in Greece who responded to conventional antidepressant monotherapy treatments for major depressive disorder (MDD)","volume":"314","author":"Papalexi","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.07.018_bb0190","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.comppsych.2016.06.004","article-title":"Self-evaluation and objective assessment of cognition in major depression and attention deficit disorder: implications for clinical practice","volume":"70","author":"Potvin","year":"2016","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jad.2024.07.018_bb0195","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/07853890109002087","article-title":"EQ-5D: a measure of health status from the EuroQol group","volume":"33","author":"Rabin","year":"2001","journal-title":"Ann. Med."},{"key":"10.1016\/j.jad.2024.07.018_bb0200","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jad.2013.02.022","article-title":"Validity and reliability of a rating scale on subjective cognitive deficits in bipolar disorder (COBRA)","volume":"150","author":"Rosa","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.07.018_bb0205","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1745-0179-3-5","article-title":"Validity and reliability of the functioning assessment short test (FAST) in bipolar disorder","volume":"3","author":"Rosa","year":"2007","journal-title":"Clin. Pract. Epidemiol. Ment. Health"},{"key":"10.1016\/j.jad.2024.07.018_bb0210","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/YIC.0000000000000074","article-title":"Functional impairment in patients with major depression in clinical remission: results from the VIVAL-D-rem, a nationwide, naturalistic, cross-sectional survey","volume":"30","author":"Sacchettia","year":"2015","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.07.018_bb0215","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jad.2017.06.034","article-title":"Treatment of neurocognitive symptoms in unipolar depression: a systematic review and future perspectives","volume":"221","author":"Salagre","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.07.018_bb0220","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jad.2018.02.031","article-title":"Biased neurocognitive self-perception in depressive and in healthy persons","volume":"232","author":"Schwert","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.07.018_bb0225","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.euroneuro.2018.11.1104","article-title":"Discrepancy between objective and subjective cognition in major depressive disorder","volume":"29","author":"Serra-Blasco","year":"2019","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"Suppl. 3","key":"10.1016\/j.jad.2024.07.018_bb0230","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004850-199606003-00015","article-title":"The measurement of disability","volume":"11","author":"Sheehan","year":"1996","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.07.018_bb0235","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jad.2017.02.029","article-title":"Restoring function in major depressive disorder: a systematic review","volume":"215","author":"Sheehan","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.07.018_bb0240","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/YIC.0b013e3282f2b4d6","article-title":"Assessing treatment effects in clinical trials with the discan metric of the Sheehan disability scale","volume":"23","author":"Sheehan","year":"2008","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.07.018_bb0245","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1038\/s41598-017-04353-w","article-title":"Discrepancy between objective and subjective cognition in adults with major depressive disorder","volume":"7","author":"Srisurapanont","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jad.2024.07.018_bb0250","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1037\/0096-3445.121.1.15","article-title":"Studies of interference in serial verbal reactions","volume":"121","author":"Stroop","year":"1992","journal-title":"J. Exp. Psychol. General."},{"key":"10.1016\/j.jad.2024.07.018_bb0255","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00406-022-01487-5","article-title":"In pursuit of full recovery in major depressive disorder","volume":"273","author":"Vicent-Gil","year":"2023","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2024.07.018_bb0265","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.2147\/NDT.S195505","article-title":"Cognitive symptoms in major depressive disorder: associations with clinical and functional outcomes in a 6-month, non-interventional, prospective study in China","volume":"15","author":"Wang","year":"2019","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2024.07.018_bb0270","series-title":"Wechsler Adult Intelligence Scale","author":"Wechsler","year":"1997"},{"key":"10.1016\/j.jad.2024.07.018_bb0275","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1179\/2042618612Y.0000000001","article-title":"Clinimetrics corner: a closer look at the minimal clinically important difference (MCID)","volume":"20","author":"Wright","year":"2012","journal-title":"J. Man. Manip. Ther."},{"key":"10.1016\/j.jad.2024.07.018_bb0280","article-title":"Remission of symptoms is not equal to functional recovery: psychosocial functioning impairment in major depression","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jad.2024.07.018_bb0285","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jad.2023.08.049","article-title":"The differences of event-related potential components in patients with comorbid depression and anxiety, depression, or anxiety alone","volume":"340","author":"Zhou","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.07.018_bb0290","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2024.07.018_bb0295","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/da.22837","article-title":"Validity of the DSM-5 anxious distress specifier for major depressive disorder","volume":"36","author":"Zimmerman","year":"2019","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jad.2024.07.018_bb0300","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1176\/appi.ajp.163.1.148","article-title":"How should remission from depression be defined? The depressed patient\u2019s perspective","volume":"163","author":"Zimmerman","year":"2006","journal-title":"Am. J. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032724010760?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032724010760?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T23:04:03Z","timestamp":1725145443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032724010760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":60,"alternative-id":["S0165032724010760"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2024.07.018","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Functioning Assessment Short Test (FAST): Clinically meaningful response threshold in patients with major depressive disorder receiving antidepressant treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2024.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}